Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT

<p><strong>Background:</strong><br /> Prostate cancer is the most common cancer among men in the UK. Prostate-specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as undertreatment of the disease. Evidence of treatment effectiveness has la...

Full description

Bibliographic Details
Main Authors:	Hamdy, FC, Donovan, JL, Lane, JA, Mason, M, Metcalfe, C, Peter Holding, Wade, J, Noble, S, Garfield, K, Young, G, Davis, M, Peters, TJ, Turner, EL, Martin, RM, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Blazeby, J, Bryant, R, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D
Other Authors:	ProtecT Study Group
Format:	Journal article
Language:	English
Published:	NIHR Journals Library 2020

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT

Similar Items